Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001144204-07-060373
Filing Date
2007-11-13
Accepted
2007-11-13 14:45:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 v093565_f-3.htm F-3/A 780497
2 GRAPHIC logo1.jpg GRAPHIC 8450
3 GRAPHIC logo2.jpg GRAPHIC 12056
4 GRAPHIC logo3.jpg GRAPHIC 7270
5 filename5.htm CORRESP 27286
  Complete submission text file 0001144204-07-060373.txt   847871
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: F-3/A | Act: 33 | File No.: 333-147024 | Film No.: 071237180
SIC: 2834 Pharmaceutical Preparations